This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
In Gothenburg
Why is this study shown?
This study includes Bipolarity among several conditions.
Bipolarity, DepressionDrugA study involving a medication or substance.
This study is looking at whether a digital support tool can help people with Schizophrenia, bipolarity, major depression, or PTSD. Participants take part in the therapy or support program and complete follow-up questionnaires or assessments.
In Minneapolis
Why is this study shown?
This study includes Bipolarity among several conditions.
This study is comparing Allogeneic Bone Marrow Derived Multipotent Mesenchymal Stromal Cells (MSCs) with placebo for people with Treatment-resistant Depression in bipolarity. Participants receive Allogeneic Bone Marrow Derived Multipotent Mesenchymal Stromal Cells (MSCs) or placebo and complete study visits and assessments.
In Houston
Why is this study shown?
This study includes Bipolarity among several conditions.
Depression, BipolarityBiologicalFrom 18 Years to 65 Years
Countries
United States
Sponsor
The University of Texas Health Science Center, Houston
This observational study is following people with depression, Suicide prevention, or bipolarity to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
In Montpellier
Why is this study shown?
This study includes Bipolarity among several conditions.
Suicidality, Depression, ...BiologicalOver 18 Years
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.